Literature DB >> 23122578

Placental steroidogenesis in pregnant women with polycystic ovary syndrome.

Manuel Maliqueo1, Hernán E Lara, Fernando Sánchez, Bárbara Echiburú, Nicolás Crisosto, Teresa Sir-Petermann.   

Abstract

OBJECTIVE: To evaluate the placental activity of steroid sulfatase (STS), 3β-hydroxysteroid dehydrogenase type 1 (3β-HSD-1) and P450 aromatase (P450arom) in polycystic ovarian syndrome (PCOS) compared to normal pregnant women.
DESIGN: Twenty pregnant women with PCOS and 30 control pregnant women who delivered at term were studied. Samples of placental tissue and cord blood were obtained after delivery. A maternal blood sample was obtained during the 34th week of gestation. In placental tissue, the activities of STS, 3β-HSD-1 and P450arom were evaluated. In the blood samples, progesterone, DHEAS, DHEA, androstenedione, testosterone, estrone, estradiol and total estriol were determined. RESULT: In placental tissue from women with PCOS, higher 3β-HSD-1 and lower P450 aromatase activities were observed compared to control women. Moreover, women with PCOS showed higher androstenedione and testosterone concentrations compared to normal pregnant women (p=0.016 and p=0.025, respectively). In cord blood, female newborns of women with PCOS exhibited lower androstenedione and higher estriol concentrations compared to daughters of control women (p=0.038; p=0.031, respectively).
CONCLUSION: These data suggest that placental tissue from women with PCOS shows changes in the activities of two important enzymes for steroid synthesis, higher 3β-HSD-1 and lower P450, which could increase androgen production during pregnancy.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23122578     DOI: 10.1016/j.ejogrb.2012.10.015

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  64 in total

1.  Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure.

Authors:  E S Barrett; K M Hoeger; S Sathyanarayana; D H Abbott; J B Redmon; R H N Nguyen; S H Swan
Journal:  J Dev Orig Health Dis       Date:  2018-01-09       Impact factor: 2.401

2.  Should we change our mind about second trimester biochemical aneuploidy screening markers of patients with polycystic ovary syndrome?

Authors:  V Korkmaz; Z Kurdoglu; Y Ergun
Journal:  J Endocrinol Invest       Date:  2015-06-16       Impact factor: 4.256

3.  Where does polycystic ovary syndrome come from?

Authors:  Roy Homburg
Journal:  Ann Transl Med       Date:  2018-09

Review 4.  Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy.

Authors:  David H Abbott; Daniel A Dumesic; Jon E Levine
Journal:  Expert Rev Endocrinol Metab       Date:  2019-02-15

5.  Developmental programming: exposure to testosterone excess disrupts steroidal and metabolic environment in pregnant sheep.

Authors:  B Abi Salloum; A Veiga-Lopez; D H Abbott; C F Burant; V Padmanabhan
Journal:  Endocrinology       Date:  2015-03-12       Impact factor: 4.736

Review 6.  Mechanisms of intergenerational transmission of polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Luis R Hoyos; Gregorio D Chazenbalk; Rajanigandha Naik; Vasantha Padmanabhan; David H Abbott
Journal:  Reproduction       Date:  2020-01       Impact factor: 3.906

Review 7.  Placental control of drug delivery.

Authors:  Sanaalarab Al-Enazy; Shariq Ali; Norah Albekairi; Marwa El-Tawil; Erik Rytting
Journal:  Adv Drug Deliv Rev       Date:  2016-08-12       Impact factor: 15.470

Review 8.  Developmental programming of insulin resistance: are androgens the culprits?

Authors:  Muraly Puttabyatappa; Robert M Sargis; Vasantha Padmanabhan
Journal:  J Endocrinol       Date:  2020-06       Impact factor: 4.286

Review 9.  Gestational Hyperandrogenism in Developmental Programming.

Authors:  Christopher Hakim; Vasantha Padmanabhan; Arpita K Vyas
Journal:  Endocrinology       Date:  2017-02-01       Impact factor: 4.736

Review 10.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.